Electrochemical detection of the human cancer biomarker ‘autocrine motility factor-phosphoglucose isomerase’ based on a biosensor formed with a monosaccharidic inhibitor

Archive ouverte

Ahmad, Lama | Salmon, Laurent | Korri-Youssoufi, Hafsa

Edité par CCSD ; Elsevier -

International audience. Human intracellular glycolytic enzyme phosphoglucose isomerase (hPGI) plays the role of autocrine motility factor (AMF) once secreted in the extracellular medium. AMF is a cytokine that stimulates tumor cell motility in vitro and metastases development in vivo. High blood levels of the protein have been reported to be closely related to metastases formation. Since it is

Suggestions

Du même auteur

Novel N-substituted 5-phosphate-d-arabinonamide derivatives as strong inhibitors of phosphoglucose isomerases: Synthesis, structure-activity relationship and crystallographic studies

Archive ouverte | Ahmad, Lama | CCSD

International audience. Phosphoglucose isomerase (PGI) is a cytosolic enzyme that catalyzes the reversible interconversion of d-glucose 6-phosphate and d-fructose 6-phosphate in glycolysis. Outside the cell, PGI is ...

Crystal structure of phosphomannose isomerase from Candida albicans complexed with 5-phospho-d-arabinonhydrazide

Archive ouverte | Ahmad, Lama | CCSD

International audience. Type I phosphomannose isomerases (PMIs) are zinc-dependent monofunctional metalloenzymes catalysing the reversible isomerization of d-mannose 6-phosphate to d-fructose 6-phosphate. 5-Phospho-...

Novel dipeptide compounds, method for the production thereof and a novel therapeutic use of dipeptide compounds

Archive ouverte | Salmon, Laurent | CCSD

The invention relates to a novel therapeutic use of dipeptide compounds having formula (I). The dipeptide compounds are useful as inhibitors of beta-lactamases, in particular belonging to the class of carbapenemases. The invention...

Chargement des enrichissements...